Sandwich maker Greencore shares soar 25% after profit upgrade Date Tuesday, October 10, 2023 - 7:40 AM Description Forecast shows resilience of ‘food to go’ even as consumers’ wallets are under pressure
Sanity finally prevails in New York’s sovereign debt court battles Date Tuesday, June 04, 2024 - 9:40 AM Description A new bill will tip the balances towards issuers
Sanofi deal offers only partial headache relief Date Monday, October 21, 2024 - 8:59 AM Description The French pharma group does not seem to have extracted a knockout price
Sanofi pushes ahead with €20bn consumer healthcare spin-off Date Saturday, June 01, 2024 - 10:00 PM Description The deal is expected to be one of Europe’s largest this year as EU IPO market shows signs of recovery
Sanofi shares fall 19% after cut to profit outlook Date Friday, October 27, 2023 - 9:33 AM Description French pharma group announces consumer unit split and increased R&D investment
Sanofi shares sink on lower profit outlook and consumer unit split Date Friday, October 27, 2023 - 2:24 AM Description French drugmaker says it will probably list its consumer care division
Sanofi-Novavax licensing deal looks to boost post-pandemic vaccine sales Date Friday, May 10, 2024 - 12:00 AM Description Agreement worth up to $1.2bn includes plan for combined flu and Covid-19 shots
Sanofi: chief must prove he can win R&D game Date Thursday, December 07, 2023 - 7:59 AM Description Paul Hudson needs to convince investors that pharma group’s new blockbuster drugs will be successful
Santander considers UK exit amid frustrations with high street banking Date Saturday, January 18, 2025 - 1:25 PM Description Spanish group reviewing its presence in the country as returns lag other markets
Santander could find ditching UK depositors is uphill struggle Date Monday, January 20, 2025 - 10:00 PM Description On top of finding a buyer, putting a laggard business up for sale will raise questions over bank’s ‘core’ markets model